The WTC 2025 Organizing Committee would like to thank the following companies for their support:
Diamond Level
CareDx, Inc., based out of Brisbane, California, is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions.
Natera provides advanced DNA technology that enables transplant providers to deliver quality, personalized care. As a diagnostics company with proprietary bioinformatics and molecular technology, we’ve performed more than 10 million cfDNA tests and are dedicated to improving kidney, heart and lung care for good. Learn more at natera.com/organ-health.
Platinum Level
TransMedics is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. We developed the Organ Care System, or the OCS, to replace a decades-old standard of care that we believe is significantly limiting access to life-saving transplant therapy for hundreds of thousands of patients worldwide. Our innovative OCS technology replicates many aspects of the organ’s natural living and functioning environment outside of the human body. As such, the OCS represents a paradigm shift that transforms organ preservation for transplantation from a static state to a dynamic environment that enables new capabilities, including organ optimization and assessment.
Veloxis Pharmaceuticals, Inc., an Asahi Kasei company, is a fully integrated specialty pharmaceutical company committed to improving the lives of transplant patients. Headquartered in Cary, North Carolina, USA, Veloxis is focused on the global development and commercialization of medications utilized by transplant patients and by patients with serious related diseases. For further information, please visit Veloxis.com.
Gold Level
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram.
Diatiro is rethinking transplantation with human-centered design and biodesign-driven innovation. The KidneyPod™ creates a stable 4°C (39°F) microclimate around the kidney during anastomosis, using phase-change technology and aerospace-grade insulation to protect the organ when it matters most. Built by surgeons, for surgeons, it’s precise, efficient, and seamless.
Eledon is dedicated to significantly improve both the longevity of the organ and the overall health and quality of life for transplant recipients. Our lead compound is tegoprubart, an anti-CD40L antibody with broad therapeutic potential to regulate drivers that can lead to the immune system attacking and rejecting transplanted organs.
From pre-transplant protocols and screening to post-transplant diagnostics and rejection monitoring, the journey is perpetual. Enhancing patient outcomes necessitates the utilization of cutting-edge technology throughout every step of the patient’s path. This is where Eurofins Transplant excels. Eurofins Transplant revolutionizes transplant testing, offering breakthrough solutions that empower both patients and providers alike. Comprising five key divisions within Eurofins: Cell TX, Donor & Product Testing, Ascend Clinical, Viracor, and Transplant Genomics, these organizations collectively influence every critical stage in the transplant journey.
www.eurofinstransplant.com
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.
Silver Level
At Apellis, we combine courageous science and compassion to develop life-changing medicines for some of the most challenging diseases patients face. Our goal is to transform treatment for a broad range of debilitating diseases by controlling a part of the immune system known as the complement cascade. We ushered in the first new class of complement medicine in 15 years, and now have two approved medicines targeting C3, the central protein in the cascade. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases.
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world. Founded in 1978, Biogen has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease.
Bridge to Life Ltd is a market leader in organ preservation solutions, offering premier products such as Belzer UW®, EasiSlush® and the VitaSmart Hypothermic Oxygenated Perfusion System. With a strong focus on product quality, innovation and accessibility, the company serves and partners with leading Transplant Centers and Organ Procurement Offices globally.
IGL specializes in medical technology for donor organ and tissue preservation. Founded by Georges Antoine Lopez, inspired by his father's transplants, IGL is devoted to creating safe, innovative solutions that ensure transplantation success and enhance patient quality of life. Decades of research and expertise define IGL's trusted reputation.
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.
Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to preservation that represents a significant improvement over the traditional standard of care.
Paragonix Advanced Organ Preservation devices combine clinically-proven, stable cooling techniques with digital tracking and monitoring technologies to provide clinicians complete control and oversight throughout the donor organ journey. The clinical impact of Paragonix preservation technology is reinforced by the GUARDIAN clinical registries, the largest database of organ preservation data in the world that analyzes post-transplant outcomes in transplant recipients.
Founded in 1998, XVIVO is the only MedTech company dedicated to extending the life of all major organs – so transplant teams around the world can save more lives.
XVIVO’s innovative technologies enable clinicians and researchers around the world to preserve, transport and assess organs outside the body.
Our pioneering technologies have been clinically proven to increase utilization of donated organs and improve transplantation outcomes.
(www.xvivogroup.com)
Bronze Level
ALS engineers innovative and agile protective solutions targeting the key molecular pathways implicated in IRI. By protecting organs from IRI, ALS optimizes graft function recovery throughout the transplantation journey thereby improving patients’ survival and outcomes.
Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality. Furthermore, we are also looking beyond our foundational Rx focus to create Rx+® healthcare solutions that combine our expertise and knowledge with cutting-edge technology in different fields of external partners. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into VALUE for patients. For more information, please visit our website at https://www.astellas.com/en.
CSL Vifor is a global pharmaceutical company that aims to become the global leader in iron deficiency, nephrology, and cardio-renal therapies. CSL Vifor strives to help patients with severe and chronic diseases lead better, healthier lives. The company develops, manufactures, and markets pharmaceutical products for precision patient care.
CTI Clinical Trial and Consulting, a global leader in research services, provides support across the clinical development lifecycle. With unmatched expertise in transplantation, CTI has contributed to nearly all transplant-related therapies, from organ preservation to post-transplant care. In its third decade, CTI ranks among the top 20 CROs.
Diatiro is rethinking transplantation with human-centered design and biodesign-driven innovation. The KidneyPod™ creates a stable 4°C (39°F) microclimate around the kidney during anastomosis, using phase-change technology and aerospace-grade insulation to protect the organ when it matters most. Built by surgeons, for surgeons, it’s precise, efficient, and seamless.
Donor Network West is a federally designated nonprofit 501(c)3 Organ Procurement Organization (OPO) with headquarters in northern California and northern Nevada. Our organization is committed to helping save and heal lives, supporting donor families and developing organ donation as a fundamental human responsibility.
Hansa Biopharma is a Swedish biopharmaceutical company focused on developing innovative, lifesaving, and life-changing treatments for patients with rare immunological conditions. Hansa has developed a first-in-class Immunoglobulin-G (IgG) antibody-cleaving enzyme therapy, imlifidase.
Find out more at https://hansabiopharma.com.
Address: Scheelevägen 22, 223 63 Lund, Sweden
Phone: +46 46 16 56 70
HistoSonics is a venture-backed medical device start-up company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy. The company’s new platform delivers personalized, tissue-specific treatments with precision and control, and without the undesirable side effects of many of today’s interventional and surgical modalities.
IGL specializes in medical technology for donor organ and tissue preservation. Founded by Georges Antoine Lopez, inspired by his father's transplants, IGL is devoted to creating safe, innovative solutions that ensure transplantation success and enhance patient quality of life. Decades of research and expertise define IGL's trusted reputation.
IGL specializes in medical technology for donor organ and tissue preservation. Founded by Georges Antoine Lopez, inspired by his father's transplants, IGL is devoted to creating safe, innovative solutions that ensure transplantation success and enhance patient quality of life. Decades of research and expertise define IGL's trusted reputation.
OrganOx is at the forefront of changing the way donor organs are preserved in the critical time between donation and transplantation. Our leading product, the metra®, harnesses patented normothermic machine perfusion technology to preserve donor livers prior to transplant.
From the success of LifePort Kidney Transporter, Organ Recovery Systems introduces the next generation of preservation with the upcoming launch of the LifePort Liver Transporter. In addition to providing innovative products, ORS delivers support via the LifePort mobile app, 24/7 Perfusion Helpline, Instructor-Led Training, and online Client Community.
MedSleuth is transforming the way patients participate in their healthcare. MedSleuth allows patients to easily provide those portions of their medical histories most relevant for a given episode of care. We invite you to take a deeper look and see how this could help you!
NORA (Nationwide Organ Recovery Transport Alliance) works with OPOs, Transplant Centers and other recovery partners throughout the country to provide the perfect “One Call Solution” for Air and Ground Organ Recovery Transportation. Efficiency, attention to detail, understanding critical time management, budget constraints and the importance your program plays in the community make NORA the perfect addition to the Organ Donation, Procurement and Transplantation processes.
Northernmost (Edmonton, Alberta, Canada) is developing a new kidney pump.
As the government contractor managing the OPTN for over 40 years, UNOS works with OPOs, hospitals, and industry partners every day to increase the number of successful transplants and improve patient outcomes. UNOS also offers transplant-focused research and consulting services, organ tracking tools, business intelligence dashboards, and training materials.
Valiant AI leverages artificial intelligence and machine learning to address the organ donor shortage, revolutionizing kidney transplantation. By analyzing vast data, their innovative solutions optimize donor-recipient matching, predict organ viability, and enhance transplant success rates, eliminating delays and improving patient outcomes in healthcare.
